<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36443440</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5403</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Cell death and differentiation</Title><ISOAbbreviation>Cell Death Differ</ISOAbbreviation></Journal><ArticleTitle>SPY1 inhibits neuronal ferroptosis in amyotrophic lateral sclerosis by reducing lipid peroxidation through regulation of GCH1 and TFR1.</ArticleTitle><Pagination><StartPage>369</StartPage><EndPage>382</EndPage><MedlinePgn>369-382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41418-022-01089-7</ELocationID><Abstract><AbstractText>Ferroptosis is an iron-dependent cell death with the accumulation of lipid peroxidation and dysfunction of antioxidant systems. As the critical regulator, glutathione peroxidase 4 (GPX4) has been demonstrated to be down-regulated in amyotrophic lateral sclerosis (ALS). However, the mechanism of ferroptosis in ALS remains unclear. In this research, bioinformatics analysis revealed a high correlation between ALS, ferroptosis, and Speedy/RINGO cell cycle regulator family member A (SPY1). Lipid peroxidation of ferroptosis in hSOD1G93A cells and mice was generated by TFR1-imported excess free iron, decreased GSH, mitochondrial membrane dysfunction, upregulated ALOX15, and inactivation of GCH1, GPX4. SPY1 is a "cyclin-like" protein that has been proved to enhance the viability of hSOD1<sup>G93A</sup> cells by inhibiting DNA damage. In our study, the decreased expression of SPY1 in ALS was resulted from unprecedented ubiquitination degradation mediated by MDM2 (a nuclear-localized E3 ubiquitin ligase). Further, SPY1 was identified as a novel ferroptosis suppressor via alleviating lipid peroxidation produced by dysregulated GCH1/BH4 axis (a resistance axis of ferroptosis) and transferrin receptor protein 1 (TFR1)-induced iron. Additionally, neuron-specific overexpression of SPY1 significantly delayed the occurrence and prolonged the survival in ALS transgenic mice through the above two pathways. These results suggest that SPY1 is a novel target for both ferroptosis and ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongyong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Chaohua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai JiaoTong University School of Medicine, Shanghai No. 9 People's Hospital, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chunting</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei City, Anhui Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Shi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Xiaoli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Xingli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenmo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5062-8846</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China. fenghonglin186@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Differ</MedlineTA><NlmUniqueID>9437445</NlmUniqueID><ISSNLinking>1350-9047</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.5.4.16</RegistryNumber><NameOfSubstance UI="C000597358">Gch1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.4.16</RegistryNumber><NameOfSubstance UI="D006136">GTP Cyclohydrolase</NameOfSubstance></Chemical><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance UI="D007501">Iron</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011990">Receptors, Transferrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C529672">Spy1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C480029">Tfrc protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006136" MajorTopicYN="Y">GTP Cyclohydrolase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007501" MajorTopicYN="N">Iron</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011990" MajorTopicYN="Y">Receptors, Transferrin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>28</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36443440</ArticleId><ArticleId IdType="pmc">PMC9950139</ArticleId><ArticleId IdType="doi">10.1038/s41418-022-01089-7</ArticleId><ArticleId IdType="pii">10.1038/s41418-022-01089-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108:822&#x2013;42. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;5. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060&#x2013;72. doi: 10.1016/j.cell.2012.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId><ArticleId IdType="pmc">PMC3367386</ArticleId><ArticleId IdType="pubmed">22632970</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28:2029&#x2013;44. doi: 10.1038/s41418-021-00814-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00814-y</ArticleId><ArticleId IdType="pmc">PMC8257776</ArticleId><ArticleId IdType="pubmed">34099897</ArticleId></ArticleIdList></Reference><Reference><Citation>Petillon C, Hergesheimer R, Puy H, Corcia P, Vourc&#x2019;h P, Andres C, et al. The relevancy of data regarding the metabolism of iron to our understanding of deregulated mechanisms in ALS; Hypotheses and Pitfalls. Front Neurosci. 2019;12:1031. doi: 10.3389/fnins.2018.01031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.01031</ArticleId><ArticleId IdType="pmc">PMC6341213</ArticleId><ArticleId IdType="pubmed">30697143</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadzhieva M, Kirches E, Wilisch-Neumann A, Pachow D, Wallesch M, Schoenfeld P, et al. Dysregulation of iron protein expression in the hSOD1G93A model of amyotrophic lateral sclerosis. Neuroscience. 2013;230:94&#x2013;101. doi: 10.1016/j.neuroscience.2012.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.11.021</ArticleId><ArticleId IdType="pubmed">23178912</ArticleId></ArticleIdList></Reference><Reference><Citation>Orrell RW, Lane RJ, Ross M. Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2007;1:CD002829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8985756</ArticleId><ArticleId IdType="pubmed">17253482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadzhieva M, Kirches E, Mawrin C. Review: iron metabolism and the role of iron in neurodegenerative disorders. Neuropathol Appl Neurobiol. 2014;40:240&#x2013;57. doi: 10.1111/nan.12096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12096</ArticleId><ArticleId IdType="pubmed">24164678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhang X, Chen S, Zhang X, Zhang S, Youdium M, et al. Prevention of motor neuron degeneration by novel iron chelators in SOD1(hSOD1G93A) transgenic mice of amyotrophic lateral sclerosis. Neurodegener Dis. 2011;8:310&#x2013;21. doi: 10.1159/000323469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000323469</ArticleId><ArticleId IdType="pubmed">21346313</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilditch-Maguire P, Trettel F, Passani LA, Auerbach A, Persichetti F, MacDonald ME. Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet. 2000;9:2789&#x2013;97. doi: 10.1093/hmg/9.19.2789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.19.2789</ArticleId><ArticleId IdType="pubmed">11092755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Xie W, Qu S, Pan T, Wang X, Le W. Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. Biochem Biophys Res Commun. 2005;333:544&#x2013;9. doi: 10.1016/j.bbrc.2005.05.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.05.150</ArticleId><ArticleId IdType="pubmed">15950935</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma T, Kobayashi S, Sato H, Fujii J. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro. Exp Cell Res. 2019;384:111592. doi: 10.1016/j.yexcr.2019.111592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.111592</ArticleId><ArticleId IdType="pubmed">31479686</ArticleId></ArticleIdList></Reference><Reference><Citation>Southon A, Szostak K, Acevedo KM, Dent KA, Volitakis I, Belaidi AA, et al. CuII (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease. Br J Pharm. 2020;177:656&#x2013;67. doi: 10.1111/bph.14881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14881</ArticleId><ArticleId IdType="pmc">PMC7012947</ArticleId><ArticleId IdType="pubmed">31655003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Hambright WS, Na R, Ran Q. Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J Biol Chem. 2015;290:28097&#x2013;106. doi: 10.1074/jbc.M115.680090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.680090</ArticleId><ArticleId IdType="pmc">PMC4653669</ArticleId><ArticleId IdType="pubmed">26400084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Tomas D, Perera ND, Cuic B, Luikinga S, Viden A, et al. Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis. Cell Death Differ. 2022;29:1187&#x2013;98. doi: 10.1038/s41418-021-00910-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00910-z</ArticleId><ArticleId IdType="pmc">PMC9177596</ArticleId><ArticleId IdType="pubmed">34857917</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo T, Adachi-Tominari K, Sano O, Kamei T, Nogami M, Ogi K, et al. Involvement of ferroptosis in human motor neuron cell death. Biochem Biophys Res Commun. 2021;566:24&#x2013;29. doi: 10.1016/j.bbrc.2021.05.095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.05.095</ArticleId><ArticleId IdType="pubmed">34111668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Na R, Danae McLane K, Thompson CS, Gao J, Wang X, et al. Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1hSOD1G93A mice. Sci Rep. 2021;11:12890. doi: 10.1038/s41598-021-92369-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92369-8</ArticleId><ArticleId IdType="pmc">PMC8213805</ArticleId><ArticleId IdType="pubmed">34145375</ArticleId></ArticleIdList></Reference><Reference><Citation>Fifield BA, Qemo I, Kirou E, Cardiff RD, Porter LA. The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis. Breast Cancer Res. 2019;21:140. doi: 10.1186/s13058-019-1211-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13058-019-1211-3</ArticleId><ArticleId IdType="pmc">PMC6907270</ArticleId><ArticleId IdType="pubmed">31829284</ArticleId></ArticleIdList></Reference><Reference><Citation>Golipour A, Myers D, Seagroves T, Murphy D, Evan GI, Donoghue DJ, et al. The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis. Cancer Res. 2008;68:3591&#x2013;3600. doi: 10.1158/0008-5472.CAN-07-6453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-07-6453</ArticleId><ArticleId IdType="pubmed">18483240</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter LA, Dellinger RW, Tynan JA, Barnes EA, Kong M, Lenormand JL, et al. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J Cell Biol. 2002;157:357&#x2013;66. doi: 10.1083/jcb.200109045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200109045</ArticleId><ArticleId IdType="pmc">PMC2173287</ArticleId><ArticleId IdType="pubmed">11980914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubanska D, Market-Velker BA, deCarvalho AC, Mikkelsen T, Fidalgo da Silva E, Porter LA. The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma. Cancer Cell. 2014;25:64&#x2013;76. doi: 10.1016/j.ccr.2013.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2013.12.006</ArticleId><ArticleId IdType="pubmed">24434210</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath DA, Fifield BA, Marceau AH, Tripathi S, Porter LA, Rubin SM. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins. EMBO J. 2017;36:2251&#x2013;62. doi: 10.15252/embj.201796905.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201796905</ArticleId><ArticleId IdType="pmc">PMC5706343</ArticleId><ArticleId IdType="pubmed">28666995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PH, Wu J, Ding CC, Lin CC, Pan S, Bossa N, et al. Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death Differ. 2020;27:1008&#x2013;22. doi: 10.1038/s41418-019-0393-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-019-0393-7</ArticleId><ArticleId IdType="pmc">PMC7206124</ArticleId><ArticleId IdType="pubmed">31320750</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266&#x2013;82. doi: 10.1038/s41580-020-00324-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00324-8</ArticleId><ArticleId IdType="pmc">PMC8142022</ArticleId><ArticleId IdType="pubmed">33495651</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh D, O&#x2019;Brien NA, Zandkarimi F, Tong DR, Stokes ME, Dunn DE, et al. MDM2 and MDMX promote ferroptosis by PPAR&#x3b1;-mediated lipid remodeling. Genes Dev. 2020;34:526&#x2013;43. doi: 10.1101/gad.334219.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.334219.119</ArticleId><ArticleId IdType="pmc">PMC7111265</ArticleId><ArticleId IdType="pubmed">32079652</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XD, Zhu MW, Shan D, Wang SY, Yin X, Yang YQ, et al. Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in response to mutant SOD1-induced DNA damage. DNA Repair. 2019;74:51&#x2013;62. doi: 10.1016/j.dnarep.2018.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2018.12.005</ArticleId><ArticleId IdType="pubmed">30630676</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger CS, Boill&#xe9;e S, Cleveland DW. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc Natl Acad Sci USA. 2007;104:7319&#x2013;26. doi: 10.1073/pnas.0702230104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0702230104</ArticleId><ArticleId IdType="pmc">PMC1863491</ArticleId><ArticleId IdType="pubmed">17463094</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxf) 2020;2020:baaa021. doi: 10.1093/database/baaa021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baaa021</ArticleId><ArticleId IdType="pmc">PMC7100629</ArticleId><ArticleId IdType="pubmed">32219413</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1&#x2013;13. doi: 10.1093/nar/gkn923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn923</ArticleId><ArticleId IdType="pmc">PMC2615629</ArticleId><ArticleId IdType="pubmed">19033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier O, B&#xf6;hm J, Dahm M, Br&#xfc;ck S, Beyer C, Johann S. Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration. Neurochem Int. 2013;62:1029&#x2013;38. doi: 10.1016/j.neuint.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2013.03.008</ArticleId><ArticleId IdType="pubmed">23562846</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YQ, Zheng YH, Zhang CT, Liang WW, Wang SY, Wang XD, et al. Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis. Neurobiol Dis. 2020;134:104648. doi: 10.1016/j.nbd.2019.104648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104648</ArticleId><ArticleId IdType="pubmed">31676238</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xie P, Lu L, Wang J, Diao L, Liu Z, et al. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017;8:347. doi: 10.1038/s41467-017-00299-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00299-9</ArticleId><ArticleId IdType="pmc">PMC5570908</ArticleId><ArticleId IdType="pubmed">28839186</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeill E, Stylianou E, Crabtree MJ, Harrington-Kandt R, Kolb AL, Diotallevi M, et al. Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin. Nat Commun. 2018;9:5409. doi: 10.1038/s41467-018-07714-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07714-9</ArticleId><ArticleId IdType="pmc">PMC6302098</ArticleId><ArticleId IdType="pubmed">30573728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong C, Liang W, Zhang C, Wang Y, Yang Y, Wang X, et al. PAK4 suppresses motor neuron degeneration in hSOD1hSOD1G93A -linked amyotrophic lateral sclerosis cell and rat models. Cell Prolif. 2021;54:e13003. doi: 10.1111/cpr.13003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.13003</ArticleId><ArticleId IdType="pmc">PMC8016643</ArticleId><ArticleId IdType="pubmed">33615605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda N, Shah SV, Endonuclease-induced DNA. damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest. 1992;90:2593&#x2013;7. doi: 10.1172/JCI116154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI116154</ArticleId><ArticleId IdType="pmc">PMC443419</ArticleId><ArticleId IdType="pubmed">1334979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49&#x2013;89. doi: 10.1089/ars.2007.9.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2007.9.49</ArticleId><ArticleId IdType="pubmed">17115887</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarina A, Santamaria PG, Nebreda AR. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A. FEBS Lett. 2009;583:2772&#x2013;8. doi: 10.1016/j.febslet.2009.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.07.028</ArticleId><ArticleId IdType="pubmed">19622356</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Sorkhy M, Craig R, Market B, Ard R, Porter LA. The cyclin-dependent kinase activator, Spy1A, is targeted for degradation by the ubiquitin ligase NEDD4. J Biol Chem. 2009;284:2617&#x2013;27. doi: 10.1074/jbc.M804847200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804847200</ArticleId><ArticleId IdType="pubmed">19054764</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchio C, Schang LM, Vance DE. Phosphorylation of SP1 by cyclin-dependent kinase 2 modulates the role of SP1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle. J Biol Chem. 2004;279:40220&#x2013;6. doi: 10.1074/jbc.M406468200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M406468200</ArticleId><ArticleId IdType="pubmed">15247247</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;8. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 2016;353:603&#x2013;8. doi: 10.1126/science.aaf6803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez S, Varfolomeev E, Brendza R, Stark K, Tea J, Imperio J, et al. Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS. Cell Death Differ. 2021;28:915&#x2013;31. doi: 10.1038/s41418-020-00625-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00625-7</ArticleId><ArticleId IdType="pmc">PMC7937687</ArticleId><ArticleId IdType="pubmed">32994544</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermentzaki G, Politi KA, Lu L, Mishra V, P&#xe9;rez-Torres EJ, Sosunov AA, et al. Deletion of Ripk3 prevents motor neuron death in vitro but not in vivo. eNeuro. 2019;6:ENEURO.0308-18.2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6391588</ArticleId><ArticleId IdType="pubmed">30815534</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Perera ND, Chiam MDF, Cuic B, Wanniarachchillage N, Tomas D, et al. Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS. Cell Death Differ. 2020;27:1728&#x2013;39. doi: 10.1038/s41418-019-0457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-019-0457-8</ArticleId><ArticleId IdType="pmc">PMC7206015</ArticleId><ArticleId IdType="pubmed">31745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, David S. Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2009;29:610&#x2013;9. doi: 10.1523/JNEUROSCI.5443-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5443-08.2009</ArticleId><ArticleId IdType="pmc">PMC6665152</ArticleId><ArticleId IdType="pubmed">19158288</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry SC, Kalyanaraman C, Tourdot BE, Conrad WS, Akinkugbe O, Freedman JC, et al. 15-Lipoxygenase-1 biosynthesis of 7&#x2009;S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5. J Lipid Res. 2020;61:1087&#x2013;103. doi: 10.1194/jlr.RA120000777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.RA120000777</ArticleId><ArticleId IdType="pmc">PMC7328043</ArticleId><ArticleId IdType="pubmed">32404334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, M&#xfc;ller C, Zandkarimi F, et al. GTP cyclohydrolase 1/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6:41&#x2013;53. doi: 10.1021/acscentsci.9b01063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.9b01063</ArticleId><ArticleId IdType="pmc">PMC6978838</ArticleId><ArticleId IdType="pubmed">31989025</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Qiao L, Bian Y, Sun X. GDF15 knockdown promotes Erastin-induced ferroptosis by decreasing SLC7A11 expression. Biochem Biophys Res Commun. 2020;526:293&#x2013;9. doi: 10.1016/j.bbrc.2020.03.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.079</ArticleId><ArticleId IdType="pubmed">32209255</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesci P, Za&#xef;di S, Lobsiger CS, Millecamps S, Escartin C, Seilhean D, et al. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Brain. 2015;138:53&#x2013;68. doi: 10.1093/brain/awu312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu312</ArticleId><ArticleId IdType="pmc">PMC4441079</ArticleId><ArticleId IdType="pubmed">25384799</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez AM, Mirkovic J, Stanisz ZA, Patwari FS, Yang WS. NSC-34 motor neuron-like cells are sensitized to ferroptosis upon differentiation. FEBS Open Bio. 2019;9:582&#x2013;93. doi: 10.1002/2211-5463.12577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.12577</ArticleId><ArticleId IdType="pmc">PMC6443867</ArticleId><ArticleId IdType="pubmed">30984534</ArticleId></ArticleIdList></Reference><Reference><Citation>McAndrew CW, Gastwirt RF, Donoghue DJ. The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis. Cell Cycle. 2009;8:66&#x2013;75. doi: 10.4161/cc.8.1.7451.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.8.1.7451</ArticleId><ArticleId IdType="pmc">PMC2782695</ArticleId><ArticleId IdType="pubmed">19106603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapatos G, Vunnava P, Wu Y. Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation. J Neurochem. 2007;101:1119&#x2013;33. doi: 10.1111/j.1471-4159.2007.04486.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04486.x</ArticleId><ArticleId IdType="pmc">PMC2212612</ArticleId><ArticleId IdType="pubmed">17394555</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran NS, Vunnava P, Wu Y, Kapatos G. Specificity proteins SP1 and Sp3 interact with the rat GTP cyclohydrolase I proximal promoter to regulate transcription. J Neurochem. 2008;104:1233&#x2013;48. doi: 10.1111/j.1471-4159.2007.05054.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.05054.x</ArticleId><ArticleId IdType="pmc">PMC2265209</ArticleId><ArticleId IdType="pubmed">18004997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang LJ, Zhou YJ, Xiong XM, Li NS, Zhang JJ, Luo XJ, et al. Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53/TfR1 pathway in the rat hearts after ischemia/reperfusion. Free Radic Biol Med. 2021;162:339&#x2013;52. doi: 10.1016/j.freeradbiomed.2020.10.307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.10.307</ArticleId><ArticleId IdType="pubmed">33157209</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>